Aerobiotix Supports Updates to AORN’s Sterile Technique Guidelines

Aerobiotix, LLC, a leader in medical air decontamination technology, supports the recent updates to the Association of periOperative Registered Nurses (AORN) Sterile Technique Guidelines. Effective April 18, 2024, these changes emphasize the importance of managing air quality in surgical environments to reduce the risk of Surgical Site Infections (SSIs).

Paul Ciovacco, Vice President of Sales for Aerobiotix

“Aerobiotix is committed to helping healthcare facilities meet these new guidelines: “The latest recommendations from AORN reinforce the essential role of advanced air decontamination systems in today’s operating rooms. Aerobiotix is dedicated to providing technologies like the Illuvia Sense, which meet and exceed these new standards, ensuring safer surgical environments for patients and healthcare professionals.”

Illuvia Sense, an FDA-registered Class II medical device from Aerobiotix, is known for significantly reducing airborne contaminants without interrupting hospital workflows. This system aligns with the new AORN guidelines, which recommend implementing air quality management strategies in environments where surgical and other invasive procedures are performed.

In conjunction with these guideline updates, Aerobiotix is excited to host a Continuing Education (CE) event, “Mastering Modern Sterile Techniques: A Deep Dive into the New AORN Guidelines.” Led by Dr. Hudson Garrett, this webinar is scheduled for May 23, 2024, from 1-2 p.m. (EDT) and will provide attendees with 1.0 hours of CE credits. Dr. Garrett will discuss the significant changes in the guidelines and offer insights on how healthcare professionals can apply these updates in various clinical settings.

Dr. Garrett shared his enthusiasm for the upcoming event: “Continuing programs such as this represent the perfect opportunity for healthcare professionals to apply the evidence-based recommendations from AORN so that every patient and healthcare team member can benefit from their clinical benefit. The time to improve healthcare safety is now, and together, we can raise the bar for healthcare air quality.”

Healthcare professionals, including registered nurses, infection preventionists, and risk managers, are encouraged to register for the webinar to enhance their understanding of the new guidelines and learn about comprehensive air quality management programs.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.